Medherant has appointed David Davies as head of development. David has held a variety of development roles, most recently as lead consultant at DDPC for three years and prior to that as chief development officer at Futura Medical, where he was part of the senior management team that took the company through to its admission to AIM, helping to grow the company from angel investment to a market capitalisation of £50 million. In his spare time David holds three voluntary directorships – with the clinical outsourcing trade association PCMG, the charity Ordinary 2 extraordinary, and with the Red Lion Group, a medical charity.
